Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

AXDX - Accelerate Diagnostics, Inc


IEX Last Trade
1.035
0   0%

Share volume: 0
Last Updated: Thu 26 Dec 2024 02:46:23 PM CET
Surgical and Medical Instrument Manufacturing : 0.83%

PREVIOUS CLOSE
CHG
CHG%

$1.04
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
26%
Profitability 25%
Dept financing 25%
Liquidity 75%
Performance 15%
Company vs Stock growth
vs
Performance
5 Days
-7.76%
1 Month
-34.76%
3 Months
-36.69%
6 Months
-8.55%
1 Year
-75.29%
2 Year
-98.13%
Key data
Stock price
$1.04
P/E Ratio 
0.00
DAY RANGE
$1.14 - $1.52
EPS 
$0.00
52 WEEK RANGE
$0.80 - $4.28
52 WEEK CHANGE
-$74.40
MARKET CAP 
47.328 M
YIELD 
N/A
SHARES OUTSTANDING 
23.679 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
0.32
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$93,218
AVERAGE 30 VOLUME 
$70,031
Company detail
CEO: Jack Phillips
Region: US
Website: acceleratediagnostics.com
Employees: 220
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Accelerate Diagnostics, Inc. provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company was formerly known as Accelr8 Technology Corporation.

Recent news